
XTL Biopharmaceuticals Ltd. XTLB
€ 2.17
2.88%
XTL Biopharmaceuticals Ltd. DPO | XTLB
DPO Jährlich XTL Biopharmaceuticals Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | 224 | 572 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 572 | 224 | 398 |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AbbVie
ABBV
|
65.5 | $ 263.04 | 0.49 % | $ 465 B | ||
|
Фармсинтез
LIFE
|
306 | - | - | - | ||
|
Aclaris Therapeutics
ACRS
|
1.56 K | $ 5.53 | 6.02 % | $ 678 M | ||
|
ADC Therapeutics SA
ADCT
|
856 | $ 1.09 | 3.74 % | $ 139 M | ||
|
Clovis Oncology
CLVS
|
236 | - | -7.23 % | $ 13 M | ||
|
Chimerix
CMRX
|
2.38 K | - | - | $ 756 M | ||
|
ADMA Biologics
ADMA
|
35.9 | $ 8.61 | 0.16 % | $ 2.05 B | ||
|
Eiger BioPharmaceuticals
EIGR
|
84.3 K | - | -9.21 % | $ 2.55 M | ||
|
Guardion Health Sciences
GHSI
|
56.8 | - | -0.31 % | $ 3.64 M | ||
|
Intercept Pharmaceuticals
ICPT
|
5.9 K | - | - | $ 643 M | ||
|
La Jolla Pharmaceutical Company
LJPC
|
162 | - | - | $ 154 M | ||
|
Merrimack Pharmaceuticals
MACK
|
360 | - | - | $ 216 M | ||
|
9 Meters Biopharma
NMTR
|
82.7 | - | -42.97 % | $ 1.05 M | ||
|
Nymox Pharmaceutical Corporation
NYMX
|
2.41 K | - | -19.68 % | $ 18.4 M | ||
|
Oncternal Therapeutics
ONCT
|
422 | - | -24.12 % | $ 1.56 M | ||
|
Opiant Pharmaceuticals
OPNT
|
175 | - | - | $ 109 M | ||
|
Orchard Therapeutics plc
ORTX
|
521 | - | 1.02 % | $ 90.8 M |